Found: 75
Select item for more details and to access through your institution.
Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 625, doi. 10.1007/s10637-016-0368-1
- By:
- Publication type:
- Article
A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [F]fluorothymidine-positron emission tomography.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 506, doi. 10.1007/s10637-012-9874-y
- By:
- Publication type:
- Article
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 1, p. 175, doi. 10.1007/s10637-009-9343-4
- By:
- Publication type:
- Article
Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 785, doi. 10.4143/crt.2023.1014
- By:
- Publication type:
- Article
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer: Single-Institution Experience.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 774, doi. 10.4143/crt.2023.1177
- By:
- Publication type:
- Article
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 2, p. 404, doi. 10.4143/crt.2023.784
- By:
- Publication type:
- Article
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 48, doi. 10.4143/crt.2023.453
- By:
- Publication type:
- Article
Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 468, doi. 10.4143/crt.2022.1342
- By:
- Publication type:
- Article
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 83, doi. 10.4143/crt.2021.1571
- By:
- Publication type:
- Article
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non–Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 767, doi. 10.4143/crt.2021.651
- By:
- Publication type:
- Article
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1112, doi. 10.4143/crt.2020.245
- By:
- Publication type:
- Article
Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 284, doi. 10.4143/crt.2019.200
- By:
- Publication type:
- Article
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 119, doi. 10.4143/crt.2018.019
- By:
- Publication type:
- Article
A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR-Tyrosine Kinase Inhibitors.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 1, p. 10, doi. 10.4143/crt.2016.058
- By:
- Publication type:
- Article
A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2014, v. 46, n. 1, p. 19, doi. 10.4143/crt.2014.46.1.19
- By:
- Publication type:
- Article
The extended leukocyte differential count using the Cytodiff flow cytometric system reveals that higher CD16+ cytotoxic NK+T lymphocyte levels predict superior survival outcomes in patients with metastatic carcinoma.
- Published in:
- Cytometry. Part B, 2013, v. 84B, n. 3, p. 202, doi. 10.1002/cyto.b.21063
- By:
- Publication type:
- Article
Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00624-0
- By:
- Publication type:
- Article
Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 3, p. 565, doi. 10.1515/cclm.2011.704
- By:
- Publication type:
- Article
Correlation of hematopoietic progenitor cell count determined by the SE-9000™ automated hematology analyzer with CD34<sup>+</sup> cell count by flow cytometry in leukapheresis products.
- Published in:
- American Journal of Hematology, 2001, v. 67, n. 1, p. 42, doi. 10.1002/ajh.1074
- By:
- Publication type:
- Article
Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP.
- Published in:
- Transfusion, 2007, v. 47, n. 8, p. 1447, doi. 10.1111/j.1537-2995.2007.01285.x
- By:
- Publication type:
- Article
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
- Published in:
- Nature Genetics, 2012, v. 44, n. 8, p. 852, doi. 10.1038/ng.2330
- By:
- Publication type:
- Article
Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer.
- Published in:
- Radiation Oncology Journal, 2015, v. 33, n. 4, p. 284, doi. 10.3857/roj.2015.33.4.284
- By:
- Publication type:
- Article
Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer.
- Published in:
- Radiation Oncology Journal, 2014, v. 32, n. 2, p. 70, doi. 10.3857/roj.2014.32.2.70
- By:
- Publication type:
- Article
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 841, doi. 10.1007/s10147-021-01869-0
- By:
- Publication type:
- Article
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4243, doi. 10.1007/s00432-022-04287-5
- By:
- Publication type:
- Article
Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4523, doi. 10.1007/s00432-022-04251-3
- By:
- Publication type:
- Article
Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2459, doi. 10.1007/s00432-021-03527-4
- By:
- Publication type:
- Article
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 11, p. 3025, doi. 10.1007/s00432-020-03293-9
- By:
- Publication type:
- Article
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
- By:
- Publication type:
- Article
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
- Published in:
- Oncologist, 2015, v. 20, n. 12, p. 1440, doi. 10.1634/theoncologist.2015-0128
- By:
- Publication type:
- Article
Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 702, doi. 10.1634/theoncologist.2013-0419
- By:
- Publication type:
- Article
Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 149, doi. 10.1111/j.1600-0609.2010.01467.x
- By:
- Publication type:
- Article
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR‐Mutated Non–Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 8, p. 1099, doi. 10.1002/jcph.1403
- By:
- Publication type:
- Article
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01).
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 24, p. 6234, doi. 10.1002/cncr.27630
- By:
- Publication type:
- Article
Multicenter Phase 2 Study of Belotecan, a New Camptothecin Analog, and Cisplatin for Chemotherapy-Naive Patients With Extensive-Disease Small Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 1, p. 132, doi. 10.1002/cncr.24719
- By:
- Publication type:
- Article
Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000.
- Published in:
- Transfusion, 2004, v. 44, n. 12, p. 1762, doi. 10.1111/j.0041-1132.2004.04166.x
- By:
- Publication type:
- Article
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 13, doi. 10.1111/j.1743-7563.2011.01398.x
- By:
- Publication type:
- Article
Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 22, doi. 10.1111/j.1743-7563.2011.01399.x
- By:
- Publication type:
- Article
Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 34, doi. 10.1111/j.1743-7563.2011.01400.x
- By:
- Publication type:
- Article
Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7174
- By:
- Publication type:
- Article
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 3, p. 705, doi. 10.1002/cam4.4476
- By:
- Publication type:
- Article